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Non-Hodgkin’s lymphoma (NHL) represents about 3% of new cancer cases[1]. Bladder 
involvement has been found in approximately 3–13% of NHL patients when studied at 
postmortem[2]. Although accounting for only 0.2% of all primary bladder tumours, the 
majority of bladder lymphomas are B-cell lymphomas. T-cell lymphoma of the bladder is 
incredibly rare. We describe a case of anaplastic, T-cell lymphoma presenting with 
haematuria and loin pain, with unilateral upper tract obstruction.   
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CASE SUMMARY 
We describe the case of a 26-year-old man with an unusual presentation of lymphoma. He was referred to 
the urology department by his general practitioner with a 3-month history of back pain, macroscopic 
haematuria, weight loss, and night sweats. He was of Pakistani origin and as a child had received a full 
course of antituberculous treatment. 
Initial investigations consisted of a renal tract ultrasound and intravenous pyelogram. The ultrasound 
scan revealed a thick-walled bladder with a heterogeneous mass arising from the bladder neck and 
prostate. A prominent left renal pelvis was also noted and a standing column of contrast in the left ureter 
to the vesicoureteric junction was seen at 1.5 h postcontrast. Rigid cystoscopy revealed a large, 
granulomatous, solid mass involving the prostate, bladder neck, trigone, and left ureteric orifice. The 
putative diagnosis at that time was tuberculosis (TB) of the bladder. The tumour was resected and 
histopathology revealed an aggressive, pleomorphic tumour. Immunohistochemistry was positive for 
ALK-1 (cytoplasmic and nuclear pattern), CD30, CD3, and CD4. Proliferation index with MIB-1 was 
high at 60% (Figs. 1–5). There were no stains for CD2, CD7, CD8, CD10, CD34, TdT, and CD79. A 
diagnosis of an ALK-positive, anaplastic, T-cell, non-Hodgkin’s lymphoma was made. No genetic or 
molecular genetic studies were performed or T-cell clonality demonstrated. A staging CT scan showed 
extensive disease, with thoracic, axillary, retrocardiac, mediastinal, retroperitoneal, mesenteric, and pelvic 
lymphadenopathy. There were also multiple pulmonary nodules and a large lytic defect in the left 
innominate bone. Incidentally, multiple calcifications in his spleen and liver consistent with prior TB 
were also seen. He was commenced on the CHOP regime of chemotherapy (cyclophosphamide, 
doxorubicin, vincristine, and prednisone). 
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FIGURE 1. High power H&E of tumour. 
 
FIGURE 2. CD30 positivity. 
 
FIGURE 3. Alk 1. 
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FIGURE 4. mib 1. 
 
FIGURE 5. CD4. 
DISCUSSION 
Urinary tract involvement in NHL is well documented, occurring in between 3 and 13% of NHL 
patients[3,4]. Bladder lymphomas are usually secondary deposits and can often be the presenting lesion of 
a previously unrecognised diffuse lymphomatous process[2]. Primary lymphoma of the bladder is very 
rare and nearly always B cell in origin[5]. There are only two reports of Hodgkin’s lymphoma of the 
urinary bladder. The majority of bladder lymphomas are marginal zone lymphomas of mucosa-associated 
lymphoid tissue[5]. ALCL (anaplastic large cell lymphoma) involving the bladder is very unusual and 
there has only been one previous case presenting with haematuria[9]. ALCL is usually associated with 
cutaneous and extranodal involvement, young age at presentation, male predominance, and is not 
associated with urinary tract symptoms. Primary systemic ALCL is typically in an advanced stage at 
presentation and the disease is rapidly progressive. These patients have an increased incidence of bone 
marrow involvement (30%) and extranodal involvement, including skin (21%), bone (17%), soft tissues 
(17%), lung (11%), and liver (8%). Systemic symptoms are observed in 75% of patients, with fever the 
most common symptom. The malignant cells stain positive for the CD30 antigen, a very sensitive but 
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nonspecific test result that is also positive in other lymphomas, including Hodgkin’s disease( CD3 and alk 
positivity in this case excludes Hodgkin’s). Most cases exhibit either T-cell or null phenotype, with 
frequent CD3 expression, cytotoxic protein expression, clonal T-cell receptor gene rearrangements by 
polymerase chain reaction (PCR), and lack of B-cell–associated markers. The primary systemic form, 
unlike the primary cutaneous form, generally stains positive for EMA and usually displays the t (2;5) 
translocation and the chimeric p80 protein with PCR and antibody studies[7]. The precise route that these 
tumours appear in the bladder is uncertain. The presence of lymphomas in the bladder may be related to 
either intrinsic foci or haematogenous spread causing tumour with multiple foci[6,8]. This case is unique, 
as T-cell lymphoma presenting with haematuria and upper tract obstruction has not previously been 
described. Lymphoma should be considered under differential diagnosis of bladder tumours, particularly 
if there are systemic symptoms or atypical features concerning the patient demographics or clinical 
history. 
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